Transplantation or dialysis for patients who have end stage renal disease with heart failure

2001 Stack, 2001, A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients, Am J Kidney Dis, 38, 992, 10.1053/ajkd.2001.28588 Hunt, 2005, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult, J Am Coll Cardiol, 46, e1, 10.1016/j.jacc.2005.08.022 Segall, 2007, Cardiovascular disease in hemodialysis and peritoneal dialysis: arguments pro hemodialysis, Nephrol Dial Transplant, 22, 59, 10.1093/ndt/gfl643 Polidori, 2002, Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity, Free Radic Biol Med, 32, 148, 10.1016/S0891-5849(01)00782-1 Spittle, 2001, Oxidative stress and inflammation in hemodialysis patients, Am J Kidney Dis, 38, 1408, 10.1053/ajkd.2001.29280 Zoccali, 2001, Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients, J Am Soc Nephrol, 12, 1508, 10.1681/ASN.V1271508 Vanholder, 2001, Uremic toxicity: present state of the art, Int J Artif Organs, 24, 695, 10.1177/039139880102401004 Wali, 2005, Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease, J Am Coll Cardiol, 45, 1051, 10.1016/j.jacc.2004.11.061 Collins, 2002, Impact of congestive heart failure and other cardiac diseases on patient outcomes, Kidney Int Suppl, S3, 10.1046/j.1523-1755.62.s81.2.x Trespalacios, 2003, Heart failure as a cause for hospitalization in chronic dialysis patients, Am J Kidney Dis, 41, 1267, 10.1016/S0272-6386(03)00359-7 Harnett, 1995, Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors, Kidney Int, 47, 884, 10.1038/ki.1995.132 Urena, 1999, Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors, Nephrologie, 20, 217 Ie, 2006, Evaluation of cardiac function in the dialysis patient—a primer for the non-expert, Nephrol Dial Transplant, 21, 1474, 10.1093/ndt/gfl167 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Cice, 2001, Dilated cardiomyopathy in dialysis patients—beneficial effects of carvedilol: a double-blind, placebo-controlled trial, J Am Coll Cardiol, 37, 407, 10.1016/S0735-1097(00)01158-X Hamad, 2001, Life-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patient, Am J Nephrol, 21, 241, 10.1159/000046255 Kammerl, 2000, Extracorporal therapy with AN69 membranes in combination with ACE inhibition causing severe anaphylactoid reactions: still a current problem?, Clin Nephrol, 53, 486 Verresen, 1994, Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes, Kidney Int, 45, 1497, 10.1038/ki.1994.195 Knoll, 2002, Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients, Am J Med, 112, 110, 10.1016/S0002-9343(01)01068-3 Sharma, 2000, Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group, Am J Cardiol, 85, 187, 10.1016/S0002-9149(99)00646-3 Han, 2007, No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance hemodialysis patients, Nephrol Dial Transplant, 22, 1150, 10.1093/ndt/gfl752 Dasgupta, 2005, Blood pressure control before and after starting dialysis, Nephron Clin Pract, 99, c86, 10.1159/000083419 Konings, 2003, Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study, Nephrol Dial Transplant, 18, 797, 10.1093/ndt/gfg147 Stack, 2003, Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States, Kidney Int, 64, 1071, 10.1046/j.1523-1755.2003.00165.x Vonesh, 2004, The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis, Kidney Int, 66, 2389, 10.1111/j.1523-1755.2004.66028.x Locatelli, 2001, Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease, J Am Soc Nephrol, 12, 2411, 10.1681/ASN.V12112411 Burt, 1989, Reversal of left ventricular dysfunction after renal transplantation, Ann Intern Med, 111, 635, 10.7326/0003-4819-111-8-635 Okouchi, 1993, Improvement of left ventricular function after renal transplantation in a patient with uremic cardiomyopathy: report of a case, Surg Today, 23, 998, 10.1007/BF00308977 Abbott, 2001, The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes, J Nephrol, 14, 369 Saad, 2006, Renal transplantation in patients with left ventricular systolic dysfunction results in a significant survival benefit when compared to patients on the waiting list, Am J Transplant, S2 Knoll, 2005, Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation, CMAJ, 173, S1, 10.1503/cmaj.1041588 Yao, 2004, Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences, Minerva Urol Nefrol, 56, 237 Ferreira, 2002, Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile, Transplantation, 74, 1580, 10.1097/00007890-200212150-00016 Rigatto, 2002, Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease, J Am Soc Nephrol, 13, 1084, 10.1681/ASN.V1341084 Abbott, 2002, Hospitalized congestive heart failure after renal transplantation in the United States, Ann Epidemiol, 12, 115, 10.1016/S1047-2797(01)00272-1